Bevacizumab + INF-α-2a: safer and therefore less costly in mRCC Clinical study 14 January 2013 Pages: 2 - 2
Novel approach used to determine cost effectiveness of ofatumumab Clinical study 14 January 2013 Pages: 4 - 4
Agomelatine fits the bill for MDD in Ireland, Hungary and Poland News item 14 January 2013 Pages: 6 - 6
Advate vs Refacto: should total treatment cost be considered? Clinical study 14 January 2013 Pages: 8 - 8
Levodopa via duodenal infusion below WTP threshold in Sweden Clinical study 14 January 2013 Pages: 8 - 8
Diethylcarbamazine: Eisai and WHO collaborate to eradicate elephantitis Media release 14 January 2013 Pages: 12 - 12
Neonatal phenylketonuria screening gives 90% ROI in Libya Clinical study 14 January 2013 Pages: 13 - 13
Population screening for chronic kidney disease not cost effective Clinical study 14 January 2013 Pages: 13 - 13
Guidelines recommend caution in use of erythropoiesis stimulants Media release 14 January 2013 Pages: 14 - 14
Policies for HPV screening and vax need to reworked in US Clinical study 14 January 2013 Pages: 14 - 14
The value of vaccines: communication breakdown in the USA Media release 14 January 2013 Pages: 14 - 14